Amoxapine
(a mox' a peen).
Click to View Image
C17H16ClN3O 313.78

Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-.
2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine [14028-44-5].
» Amoxapine contains not less than 98.5 percent and not more than 101.0 percent of C17H16ClN3O, calculated on the dried basis.
Packaging and storage— Preserve in tight containers.
USP Reference standards 11
USP Amoxapine RS Click to View Structure
Identification, Infrared Absorption 197K.
Melting range, Class I 741: between 177 and 181.
Loss on drying 731 Dry it at 105 for 4 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.1%.
Chromatographic purity—
Standard solutions— Dissolve an accurately weighed quantity of USP Amoxapine RS in chloroform, and mix to obtain Standard preparation A having a known concentration of 0.50 mg per mL. Quantitatively dilute a portion of Standard solution A with chloroform to obtain Standard solution B having a known concentration of 0.25 mg per mL.
Test solution— Dissolve an accurately weighed quantity of Amoxapine in chloroform to obtain a solution containing 50 mg per mL.
Procedure— Separately apply 5 µL of the Test solution and each of the two Standard solutions to a suitable thin-layer chromatographic plate (see Chromatography 621), coated with a 0.2-mm layer of chromatographic silica gel mixture. Allow the spots to dry, and develop the chromatogram in a solvent system consisting of a mixture of chloroform, methanol, and ammonium hydroxide (18:2:0.1) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the developing chamber, mark the solvent front, air-dry, examine the plate under short-wavelength UV light, and compare the intensities of any secondary spots observed in the chromatogram of the Test solution with those of the principal spots in the chromatograms of the Standard solutions: no secondary spot from the chromatogram of the Test solution is larger or more intense than the principal spot obtained from Standard solution B (0.5%), and the sum of the intensities of the secondary spots obtained from the Test solution corresponds to not more than 1.0%.
Assay— Transfer about 300 mg of Amoxapine, accurately weighed, to a 250-mL flask, dissolve in 50 mL of glacial acetic acid, and add 3 drops of crystal violet TS. Titrate with 0.1 N perchloric acid VS to an emerald green endpoint. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 15.69 mg of C17H16ClN3O.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ravi Ravichandran, Ph.D.
Principal Scientific Liaison
1-301-816-8330
(SM42010) Monographs - Small Molecules 4
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 2194